Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Exp Toxicol Pathol ; 62(2): 117-26, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19359153

RESUMEN

A tiered testing strategy based on a comparative chemical and biological testing program has been developed to evaluate the potential of tobacco processes, ingredients, or other technological developments to change the biological activity that results from burning tobacco. Cast sheet tobacco is a specific type of reconstituted tobacco sheet that can be used in the manufacture of cigarettes. The comparative chemical and biological testing program was used to compare the mainstream smoke and cigarette smoke condensate (CSC) from a Reference cigarette that did not contain cast sheet to that collected from Test cigarettes containing cast sheet at a final blend level of either 10% or 15%. Testing included mainstream cigarette smoke chemistry studies, in vitro studies (Ames assay, sister chromatid exchange assay, and neutral red cytotoxicity assay), and in vivo toxicology studies (13-week rat nose-only inhalation assay and 30-week mouse dermal tumor promotion assay). Certain statistically significant differences were observed in the chemical and biological studies when the Reference cigarette was compared to each of the Test cigarettes. However, when viewed collectively, the chemical and biological studies demonstrated that inclusion of cast sheet up to 15% in the final blend did not increase the inherent biological activity of mainstream cigarette smoke or CSC.


Asunto(s)
Nicotiana/química , Nicotiana/toxicidad , Preparaciones de Plantas/química , Preparaciones de Plantas/toxicidad , Fumar/efectos adversos , Animales , Células CHO , Cricetinae , Cricetulus , Femenino , Ratones , Ratones Endogámicos SENCAR , Pruebas de Mutagenicidad , Ratas , Ratas Sprague-Dawley , Intercambio de Cromátides Hermanas/efectos de los fármacos , Humo/efectos adversos
2.
Exp Lung Res ; 34(8): 513-30, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18850377

RESUMEN

This study was conducted to determine the time course of gene expression associated with specific signaling pathways in normal human bronchial epithelial (NHBE) cells after exposure to 2 concentrations of 2R4F tobacco mainstream smoke (MSS). Expression of 84 genes representing 18 signal transduction pathways was quantitated in MSS- and air-exposed cultures using real-time polymerase chain reaction (PCR) arrays at 1, 4, and 24 hours following exposure. A confidence score, calculated based on statistical analysis of the degree and reproducibility of expression changes, was used to identify potential biologically significant changes in gene expression. Stimulation of NIAP, an apoptosis inhibitor, suppression of NFKB1 and MYC, representing pro-apoptotic activity, and down-regulation of TCF7 and up-regulation of KLK2, representing anti-/pro-inflammatory responses, were altered 1 hour after exposure to the high concentration of MSS. At the 4-hour time point, the pattern had changed such that 10 different genes were now up-regulated and an additional gene was now down-regulated. Significant changes included genes involved in inflammatory response (LTA, SELPLG, and IL8), repair and wound-healing activity (MMP10), and growth activity (GREB1, EGR1), suggesting repair in this period. By 24 hours, the only up-regulated genes in common with the 4-hour profile were SELPLG and IL8, suggesting continued inflammatory signaling. These results suggest that identification of specific gene expression-based biomarkers of MSS toxicity is promising for investigating specific mechanisms of cellular damage. As expected, the expressed signals were dependent on the concentration of MSS and the postexposure times.


Asunto(s)
Bronquios/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Nicotiana , Mucosa Respiratoria/efectos de los fármacos , Humo/efectos adversos , Bronquios/metabolismo , Bronquios/patología , Células Cultivadas , Relación Dosis-Respuesta a Droga , Perfilación de la Expresión Génica , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Reproducibilidad de los Resultados , Mucosa Respiratoria/metabolismo , Mucosa Respiratoria/patología , Transducción de Señal/genética , Factores de Tiempo
3.
J Interferon Cytokine Res ; 28(12): 703-12, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18937544

RESUMEN

Bronchial epithelium is frequently exposed to air pollutants, and it is hypothesized that these cells elicit inflammatory responses as early elements in pulmonary defense. Our purpose was to evaluate changes in messenger RNA levels of 84 genes representing cytokines and receptors over a repetitive-exposure time course to further define the inflammatory responses associated with mainstream cigarette smoke (MSS) exposure in an in vitro lung model. Normal human bronchial epithelial cells were treated with mainstream cigarette smoke condensate (CSC) prepared from Kentucky 2R4F cigarettes (60 microg total particulate matter/mL media, 0.2% dimethylsulfoxide), and examined by quantitative real-time polymerase chain reaction. Applications of CSC were designed in seven groups to test immediate, early, intermediate, and late responses evaluated at the end of alternating exposure/recovery periods. Three predominant gene expression responses were observed: adaptive (return to baseline), sustained (maintained expression during treatment), and chronic (maintained expression posttreatment). Overall, 25 genes exhibited statistically significant changes: 14 genes exclusively elevated, 10 genes exclusively depressed, and 1, interleukin-8 (IL8), exhibiting both up- and downregulation in the seven groups. The most responsive genes were osteopontin (34-fold upregulation) and CXCL14 (23-fold downregulation). Our observations suggest that specific genes involved in inflammatory pathways respond to CSC in chronic, sustained, or adaptive patterns with the chronic pattern as the predominant behavior.


Asunto(s)
Bronquios/inmunología , Quimiocinas/biosíntesis , Interleucinas/biosíntesis , Nicotiana/efectos adversos , Mucosa Respiratoria/inmunología , Humo/efectos adversos , Breas/toxicidad , Adulto , Bronquios/efectos de los fármacos , Células Cultivadas , Quimiocinas CXC/biosíntesis , Regulación hacia Abajo , Células Epiteliales/efectos de los fármacos , Células Epiteliales/inmunología , Perfilación de la Expresión Génica , Humanos , Interleucina-8/biosíntesis , Masculino , Osteopontina/inmunología , Mucosa Respiratoria/efectos de los fármacos , Regulación hacia Arriba
4.
Exp Toxicol Pathol ; 59(1): 17-27, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17590321

RESUMEN

A tiered testing strategy has been employed to evaluate the potential of tobacco processes, ingredients, or technological developments to change the biological activity resulting from burning cigarette tobacco. The strategy is based on comparative chemical and biological testing. The introduction of banded cigarette papers in cigarettes to meet New York state "Fire Safety Standards for Cigarettes" constitutes an example of a technological development evaluated utilizing this tiered testing strategy that included a comparison of the chemical and biological effects of cigarettes with and without the banded cigarette paper technologies (BCPT) (representative of current marketed technologies). Specific testing included mainstream cigarette smoke chemistry studies; in vitro studies included genotoxicity (Ames and sister chromatid exchange) and cytotoxicity studies (neutral red); in vivo studies included a 13-week inhalation study in Sprague-Dawley rats and a 30-week dermal tumor promotion study in SENCAR mice. Collectively, data indicated that cigarettes with and without BCPT had a similar toxicological profile in this test battery.


Asunto(s)
Nicotiana/toxicidad , Papel , Humo/efectos adversos , Tecnología , Industria del Tabaco/métodos , Administración por Inhalación , Administración Tópica , Animales , Células CHO/efectos de los fármacos , Células CHO/metabolismo , Células CHO/patología , Supervivencia Celular/efectos de los fármacos , Cricetinae , Cricetulus , Relación Dosis-Respuesta a Droga , Femenino , Inmunosupresores/toxicidad , Masculino , Ratones , Ratones Endogámicos SENCAR , Rojo Neutro , Ratas , Ratas Sprague-Dawley , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Intercambio de Cromátides Hermanas/efectos de los fármacos , Intercambio de Cromátides Hermanas/genética , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Humo/análisis , Breas/química , Breas/toxicidad , Nicotiana/química , Pruebas de Toxicidad
5.
Food Chem Toxicol ; 42(4): 631-9, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15019188

RESUMEN

A tiered testing strategy has been developed to evaluate the potential of tobacco processes, ingredients, or technological developments to change the biological activity resulting from burning tobacco. The strategy is based on comparative chemical and biological testing. Expanded shredded tobacco stems (ESS) constitute an example of a common tobacco components expansion process currently used in the manufacture of cigarettes to increase the tobacco blend filling capacity. As part of the toxicological evaluation of ESS, test cigarettes containing 9.5%, 18.5%, and 25% ESS were compared to control cigarettes containing 0% ESS. Testing included mainstream cigarette smoke chemistry studies, genotoxicity studies (Ames and sister chromatid exchange), a 13-week inhalation study in Sprague-Dawley rats, and a 30-week dermal tumor promotion study in SENCAR mice. Collectively, data indicated that cigarettes with and without ESS had a similar toxicological profile in this test battery.


Asunto(s)
Nicotiana/toxicidad , Plantas Tóxicas , Humo/efectos adversos , Fumar , Industria del Tabaco/métodos , Animales , Células CHO , Pruebas de Carcinogenicidad , Cricetinae , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Ratones Endogámicos SENCAR , Pruebas de Mutagenicidad , Ratas , Ratas Sprague-Dawley , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Intercambio de Cromátides Hermanas/efectos de los fármacos , Piel/efectos de los fármacos , Piel/patología , Neoplasias Cutáneas/inducido químicamente , Neoplasias Cutáneas/patología , Humo/análisis
6.
Food Chem Toxicol ; 41(12): 1771-80, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14563402

RESUMEN

A tiered testing strategy has been developed to evaluate the potential for tobacco processes, ingredients, and other technological developments to increase or decrease the biological activity resulting from burning tobacco. The strategy is based on comparative chemical and biological testing. Propane expanded tobacco is an example of a processed tobacco used in the modern manufacture of cigarettes. Test cigarettes containing propane expanded tobacco were compared to control cigarettes containing tobacco expanded with a traditional expansion agent (Freon-11). The toxicological evaluation included chemistry studies using mainstream cigarette smoke (determination of selected constituent yields), in vitro studies using cigarette smoke condensate (Ames study in Salmonella typhimurium and sister chromatid exchange study in Chinese hamster ovary cells) and in vivo studies (13-week inhalation study of mainstream cigarette smoke in Sprague-Dawley rats and 30-week dermal tumor promotion study of cigarette smoke condensate in SENCAR mice). Although statistically significant differences in several smoke constituents were observed, most constituents from cigarettes containing 100% propane expanded tobacco were within market survey ranges. Furthermore, biological tests indicated that the cigarettes containing propane or Freon-11 expanded tobacco were not significantly different.


Asunto(s)
Nicotiana/química , Nicotiana/toxicidad , Propano/química , Administración por Inhalación , Administración Tópica , Animales , Carboxihemoglobina/metabolismo , Pruebas de Carcinogenicidad , Clorofluorocarburos de Metano , Femenino , Neoplasias Laríngeas/inducido químicamente , Neoplasias Laríngeas/patología , Pulmón/metabolismo , Neoplasias Pulmonares/inducido químicamente , Neoplasias Pulmonares/patología , Masculino , Mutágenos/toxicidad , Nicotina/sangre , Ratas , Ratas Sprague-Dawley , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Caracteres Sexuales , Intercambio de Cromátides Hermanas/efectos de los fármacos , Neoplasias Cutáneas/inducido químicamente , Humo/análisis
7.
Toxicol Lett ; 145(2): 107-19, 2003 Nov 30.
Artículo en Inglés | MEDLINE | ID: mdl-14581163

RESUMEN

A tiered testing strategy has been developed to evaluate the potential of tobacco processes, ingredients, or technological developments to change the biological activity resulting from burning tobacco. The strategy is based on comparative chemical and biological testing. Dry ice expanded tobacco (DIET) is an example of a common tobacco expansion process currently used in the manufacture of cigarettes to increase tobacco filling capacity. As part of the toxicological evaluation of DIET, test cigarettes containing DIET were compared with control cigarettes containing tobacco expanded with a traditional expansion agent (Freon-11, also known as trichlorofluoromethane). Testing included mainstream cigarette smoke chemistry studies, genotoxicity studies (Ames and sister chromatid exchange, SCE), a 13-week inhalation study in Sprague-Dawley rats, and a 30-week dermal tumor promotion study in SENCAR mice. Cigarettes containing DIET or Freon-11 expanded tobacco were similar in biological activity.


Asunto(s)
Hielo Seco , Nicotiana/toxicidad , Fumar/efectos adversos , Industria del Tabaco/métodos , Administración por Inhalación , Animales , Células CHO , Carboxihemoglobina/metabolismo , Pruebas de Carcinogenicidad , Clorofluorocarburos de Metano , Cricetinae , Femenino , Masculino , Ratones , Ratones Endogámicos SENCAR , Pruebas de Mutagenicidad , Nicotina/sangre , Ratas , Ratas Sprague-Dawley , Intercambio de Cromátides Hermanas , Fumar/sangre , Nicotiana/química
8.
J Toxicol Environ Health A ; 66(15): 1453-73, 2003 Aug 08.
Artículo en Inglés | MEDLINE | ID: mdl-12857635

RESUMEN

A tiered testing strategy has been developed to evaluate the potential for new ingredients, tobacco processes, and technological developments to increase or reduce the biological activity that results from burning tobacco. In the manufacture of cigarettes, honey is used as a casing ingredient to impart both aroma and taste. The primary objective of this document is to summarize and interpret chemical and toxicological studies that have been conducted to evaluate the potential impact of honey on the biological activity of either mainstream cigarette smoke or cigarette smoke condensate. As part of ongoing stewardship efforts, cigarettes produced with honey (5% wet weight) as an alternative to invert sugar in tobacco casing material were subjected to extensive evaluation. Principal components of this evaluation were a determination of selected mainstream smoke constituent yields, Ames assay, sister chromatid exchange assay in Chinese hamster ovary cells, a 30-wk dermal tumor promotion evaluation of cigarette smoke condensate in SENCAR mice, and a 13-wk inhalation study of cigarette smoke in Sprague-Dawley rats. Comparative analytical evaluations demonstrated that the substitution of honey for invert sugar as a casing material in cigarettes had no significant impact on mainstream smoke chemistry. In addition, in vitro and in vivo studies demonstrated that cigarettes containing tobacco cased with honey had comparable biological activity to cigarettes containing invert sugar. Collectively, these data demonstrate that the use of honey as an alternative casing material in the manufacture of cigarettes does not alter the potential toxicity of cigarette smoke condensate (CSC) or cigarette smoke; therefore the use of honey as an ingredient added to cigarette tobacco is acceptable from a toxicological perspective.


Asunto(s)
Miel/toxicidad , Nicotiana , Fumar , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Administración por Inhalación , Animales , Peso Corporal/efectos de los fármacos , Pruebas de Carcinogenicidad , Carcinógenos/toxicidad , Femenino , Técnicas In Vitro , Masculino , Pruebas de Mutagenicidad , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Salmonella typhimurium/efectos de los fármacos , Salmonella typhimurium/genética , Intercambio de Cromátides Hermanas/efectos de los fármacos , Neoplasias Cutáneas/inducido químicamente , Humo/análisis , Acetato de Tetradecanoilforbol/toxicidad
9.
Mutat Res ; 521(1-2): 137-49, 2002 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-12438011

RESUMEN

The US Federal Trade Commission (FTC) classifies domestic cigarettes into one of three 'tar' categories based on 'tar' and nicotine levels. The objective of the present study was to determine urine mutagenicity in groups of smokers of ultra-low 'tar' (ULT), full-flavor low 'tar' (FFLT) and full-flavor 'tar' (FF) filtered cigarettes after switching to primarily tobacco-heating Eclipse cigarettes. Sixty-seven smokers maintained a specified diet and consumed ad libitum their usual brands of cigarettes, switched to Eclipse, and switched back to their usual brands. Twenty-four hour urine samples were collected weekly, concentrated on XAD-2 resin, and tested in the Ames mutagenicity assay using bacterial strains TA98 and YG1024 with S9 metabolic activation. Daily consumption of cigarettes was not significantly different (at P<0.05) between FTC 'tar' categories and average daily cigarette consumption did not change significantly in any smoker group after switching to Eclipse cigarettes. Average urine mutagenicity was 47% less (P<0.05) for ULT than for FFLT usual brand smokers as measured by the more sensitive strain YG1024, although no significant differences (P<0.05) were observed in urine mutagenicity between usual brand FTC 'tar' categories as measured by strain TA98. The reduction in urinary mutagens in the more sensitive strain, YG1024, observed in ULT smokers as compared with higher 'tar' categories suggest reduced exposure to mutagens. Usual brand salivary cotinine in the ULT group was significantly lower (P<0.05) than the FF group and the FFLT group. Salivary cotinine did not differ significantly (at P<0.05) among the smoker groups when smoking Eclipse compared to usual brand. After switching to Eclipse, the following reductions in urinary mutagenicity were observed: ULT, 70.1+/-6.4% (TA98), 70.9+/-6.2% (YG1024); FFLT, 77.1+/-2.4% (TA98), 73.6+/-2.0% (YG1024); and FF, 76.1+/-3.5% (TA98), 71.4+/-4.0% (YG1024). Across all 'tar' categories, cigarette smokers experienced significant reductions (P<0.05) in urine mutagenicity, but not salivary cotinine, upon switching to Eclipse. The reduction in urine mutagenicity when smoking Eclipse provides supporting evidence that Eclipse may present less risk of cancer compared to cigarettes currently in the market.


Asunto(s)
Fumar/efectos adversos , Fumar/orina , Breas/efectos adversos , Cotinina/análisis , Femenino , Humanos , Masculino , Pruebas de Mutagenicidad/métodos , Saliva/metabolismo , Breas/clasificación , Nicotiana
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA